During Trypanosoma cruzi infection, CTLA-4 blockade resulted in increased NO production in vivo and in vitro, and increased resistance to infection with the Y and Colombian strains of T. cruzi, and also led to increased survival rate48. Here, CTLA4 is linked to infection.